Searched for
ORCHID PHARMA STOCK
Orchid Pharma shares in focus as U.S. FDA completes facility inspectionOrchid Pharma share price: Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosp...- Another Ruchi Soya in the making? This scrip jumps 6,100% in 4 monthsAnalysts are comparing this stellar run with the surge that Ruchi Soya shares saw after Ramdev’s Patanjali Group acquired the company last ...
- Orchid Pharma gets EIR from USFDA for its Alathur facilityOrchid Pharma today said it has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tam...
- Orchid Pharma gets final nod from USFDA for Parkinson's drugChennai-based Orchid Pharma has received final approval from the US health regulator for its generic version of rasagiline tablets.
- Orchid Chemicals rallies over 8% on USFDA nod for Eszopiclone tabletsOrchid Chemicals Ltd rallied as much as 8.07 per cent in trade on Friday, after the pharma major received approval from the USFDA.
- Orchid Chemicals surges 10% on approval of debt rejig planOrchid Chemicals surged nearly 10% on the back of reports that the CDR empowered group has approved the company's debt restructuring propos...
- Orchid Chemicals, Pharmaceuticals Ltd clear USFDA inspectionOrchid Chemicals and Pharmaceuticals Ltd has said its Cephalosporin API manufacturing (antibiotic) complex in Alathur, Chennai, has success...
- Mercator Lines is a decent traders stock: Deepak Mohoni"This has been of to a pretty decent start in the bull market and now closing in into some thing like a three-four month high. Shipping sto...
- Orchid Chemicals may move higher: Ashwani Gujral, Market StrategistIn case Orchid Chemicals results are decent, it could still have an upside of 310-315 immediately.
- Orchid Chemicals a decent stock: Ashwani GujralThis is a decent pharma stock to have particularly because Rakesh also tends to own it.
- Accumulate Strides Arcolab on every dip: Ashit SuriAshit Suri, Fundamental Research Analyst, JV Capital Services in an interview with ET Now talks about his pick from the pharma stocks.
- Target of 165 on Orchid Chemicals: Ashuu KakkarrAshuu Kakkarr, Technical Analyst, Market Strategist, www.ashuukakkarr.com, talks to ET Now on pharma companies.
- Hospira acquires Orchid Chemicals for $400 mnIt is a win-win situation for both the US-based pharma company Hospira and Chennai-based Orchid Chemicals and Pharmaceuticals.
- Orchid Chemicals deal to repair balance sheet, boost growthHospira is set to acquire Orchid Chemical’s generic injectable pharma business for $400 million.
- Orchid gets USFDA nod for injection, gets 6-mth exclusivityPharma firm Orchid Chemicals & Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam i...
- Orchid plunges 12.5% on Ranbaxy silenceOrchid Chemicals’ shares plunged 12.5% or Rs 40 to Rs 279 on Thursday from Wednesday’s close of Rs 319 at BSE.
- No hostile takeover bid for Orchid: RanbaxyRanbaxy, which has been linked to a hostile takeover bid of Orchid Chemicals, has said it does not believe in such practices.
- Ranbaxy can't pop Orchid easilySolrex will have to fork out an extra Rs 400-500 crore to buy a further 20% stake in case it comes with an open offer.
- Orchid may use warrants as defenceAs a proxy fight for the control of drug maker Orchid intensifies in the stock market, a key weapon in founder K Raghavendra Rao’s arsenal ...
- Orchid to buy out US co Bexel PharmaOrchid Chemicals & Pharmaceuticals Ltd on Monday said it plans to buyout US-based Bexel Pharmaceuticals Inc by acquiring a 26 per cent stak...
Load More
